Keyphrases
Clinical High Risk
16%
Cost-effectiveness
100%
Decision Tree
16%
Hospitalization
100%
Hospitalized Patients
16%
Incremental Cost
16%
Incremental Cost-effectiveness Ratio
33%
Inflammatory Bowel Disease
100%
Model Uncertainty
16%
Number-needed-to-treat
50%
One-way Sensitivity Analysis
16%
Patient Preference
16%
Probabilistic Analysis
16%
Probabilistic Sensitivity Analysis
16%
Quality-adjusted Life Years
100%
Risk Cost
16%
Risk Profile
16%
Rivaroxaban
50%
Societal Perspective
16%
Venous Thromboembolism
100%
Venous Thromboembolism Prophylaxis
100%
Venous Thromboembolism Risk
33%
Willingness to Pay
16%
Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Health Care Cost
38%
Inflammatory Bowel Disease
7%
Numbers Needed to Treat
23%
Patient Preference
7%
Patient with Inflammatory Bowel Disease
100%
Quality Adjusted Life Year
46%
Rivaroxaban
23%
Venous Thromboembolism
100%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Decision Trees
7%
Incremental Cost-Effectiveness Ratio
15%
Inflammatory Bowel Disease
7%
Numbers Needed to Treat
23%
Patient Preference
7%
Patient with Inflammatory Bowel Disease
100%
Quality Adjusted Life Year
46%
Rivaroxaban
23%
Venous Thromboembolism
100%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
100%
Number Needed to Treat
23%
Rivaroxaban
23%
Venous Thromboembolism
100%